Genea Biocells is pleased to announce that Dr. Friedrich Metzger has joined our core of leadership as a scientific advisor. Prof. Metzger has more than 15 years of experience in pharmaceutical R&D with a proven track record of translation into the clinic. His scientific expertise focuses mainly on therapeutic approaches in neurological and rare neuromuscular diseases, and he is the author and inventor of over 60 publications and patents. Currently, Prof. Metzger is the Chief Scientific Officer and co-founder of Versameb, a regenerative medicine R&D company and Professor of Neurobiology at the University of Freiburg, Germany. He was previously the Head of Discovery, Rare Diseases at Roche in Basel, Switzerland where he initiated multiple drug discovery programs and led them into the clinic. He participated in many due diligence processes and was part of the team that launched stem cell research at Roche.
Please follow and like us: